Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
PSA Media Partner1 min read

The Psychedelic Silver Screen, Vol. I: An Interview with Scott Paul Wright, Director of “The Next Chapter”

“Aging, Ceremony, and the Limits of Documentary Form” Produced in Partnership by Psychedelic State(s) of America and The Chronicles of Kykeon

By PSA Media Team and PSA Media Partner

Contributor ·

The Psychedelic Silver Screen, Vol. I: An Interview with Scott Paul Wright, Director of “The Next Chapter”

Related stories

Picked by shared tags, desk, and byline.

Reader comments

Join the conversation. Comments are reviewed by our editors before they appear.

0/4000

Loading comments…